Investing News Point Biopharma Drops 28% After Phase 3 Data for a Prostate Cancer Candidate September 6, 2022
Investing News AstraZeneca’s Imfinzi Got Approved by the FDA to Treat Cancer of the Biliary Tract. September 6, 2022
Investing News GSK announces an upcoming FDA AdCom conference on the treatment of renal disease September 6, 2022
Investing News Eiger Drops 21% While the Regulatory Pathway for COVID-19 Therapy Is Unknown September 6, 2022
Investing News Sanofi/Regeneron Dupixent Exhibits Effectiveness for up to 2 Years, in Children With Asthma September 6, 2022
Search
